S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
HCAT · Health Catalyst, Inc
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Health Catalyst Inc (HCAT)
NASDAQ NMS - GLOBAL MARKET
Health Care
$1.74
-0.01
(-0.57%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$1.74
$1.74
$1.76
52-WEEK RANGE
$1.74
$0.95
$3.62
What's happening
- HCAT is down 0.57% today, trading at $1.74. — Live quote
- Volume today (14,991) is well below its 3-month average of 841,080. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.04 actual vs. $0.03 estimated (+29.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 3
Hold 5
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
HCAT
-26.78%
vs S&P 500
-39.56%
1-YEAR RETURN
HCAT
-43.91%
vs S&P 500
-58.47%
6-MONTH RETURN
HCAT
+37.80%
3-MONTH RETURN
HCAT
-16.67%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.04
Est. $0.03
BEAT +29.0%
2026-04-26 (Q1 2026)
$0.02
Est. $0.02
BEAT +14.3%
2026-01-26 (Q4 2025)
$0.08
Est. $0.09
MISS -13.8%
2025-10-26 (Q3 2025)
$0.06
Est. $0.06
MISS -0.7%
Valuation Measures & Ratios
Enterprise Value4$224.2M
Forward P/E5—
PEG Ratio6-0.00
Price / Sales (TTM1)0.45
Price / Book71.46
EV4 / Revenue0.77
EV4 / EBITDA—
Profit Margin-90.61%
Operating Margin-84.36%
Return on Equity (ROE8)-129.70%
Return on Assets (ROA9)-56.93%
Avg Volume (3M)841,080
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $147.4M | $91.8M | $198.7M | $261.8M | $307.3M |
| P/E | -0.69 | -0.46 | -1.95 | -2.82 | -4.23 |
| Price/Sales | 0.49 | 0.30 | 0.64 | 0.84 | 1.00 |
| Price/Book | 1.46 | 0.66 | 0.60 | 0.75 | 0.82 |
| EV/Revenue | 0.81 | 0.60 | 1.00 | 1.17 | 1.14 |
| ROE | -213.01% | -143.31% | -30.63% | -26.75% | -19.26% |
| ROA | -59.89% | -48.03% | -17.32% | -15.09% | -8.14% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,212,809
Change from Prior Settlement+9.07%
% of Float—
Days to Cover (Short Ratio)5.20
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -12.7% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -90.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -43.9%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on HCAT
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $70.8M | $76.3M | $80.7M | $79.4M | $76.4M | $75.9M | $74.7M |
| Gross profit | — | — | $40.1M | — | — | $36.3M | — | — |
| Operating income | -$36.5M | -$106.5M | -$17.5M | -$37.1M | -$20.2M | -$13.7M | -$15.8M | -$22.8M |
| Net income | -$40.5M | -$111.0M | -$22.2M | -$41.0M | -$23.7M | -$14.7M | -$13.5M | -$20.6M |
| EPS (diluted) | $-0.55 | $-1.53 | $-0.32 | $-0.59 | $-0.35 | $-0.24 | $-0.23 | $-0.35 |
| EPS (basic) | $-0.55 | $-1.53 | $-0.32 | $-0.59 | $-0.35 | $-0.24 | $-0.23 | $-0.35 |
| Operating margin | -$52 | -$150 | -$23 | -$46 | -$25 | -$18 | -$21 | -$31 |
| Net margin | -$58 | -$157 | -$29 | -$51 | -$30 | -$19 | -$18 | -$28 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $358.6M | $412.2M | $502.6M | $587.1M | $616.2M | $891.5M | $858.9M | $813.0M |
| Total liabilities | $257.8M | $274.1M | $256.9M | $255.2M | $268.6M | $514.7M | $493.7M | $458.0M |
| Stockholders' equity | $100.8M | $138.1M | $245.8M | $331.9M | $347.5M | $376.8M | $365.2M | $355.0M |
| Total current assets | $248.4M | $182.3M | $169.3M | $165.4M | $180.6M | $422.7M | $465.6M | $457.4M |
| Total current liabilities | $91.9M | $107.6M | $89.6M | $87.9M | $98.8M | $339.6M | $325.9M | $323.8M |
| Cash & equivalents | $60.6M | $59.9M | $50.8M | $40.3M | $50.7M | $342.0M | $249.6M | $328.3M |
| Marketable securities (current) | $42.9M | $49.0M | $44.9M | $51.2M | $46.6M | $0 | $142.4M | $58.9M |
| Accounts receivable | $41.9M | $59.1M | $59.1M | $60.1M | $68.4M | $64.0M | $57.2M | $51.6M |
| Property, plant & equipment | $33.5M | $34.9M | $33.8M | $32.6M | $33.4M | $31.6M | $29.4M | $27.9M |
| Goodwill | $11.1M | $113.3M | $209.1M | $285.6M | $286.1M | $313.4M | $259.8M | $234.4M |
| Intangible assets | $56.1M | $69.3M | $77.7M | $89.6M | $98.3M | $106.4M | $86.1M | $76.5M |
| Other non-current assets | $3.6M | $6.1M | $6.1M | $6.8M | $5.4M | $5.5M | $6.0M | $5.7M |
| Accounts payable | $8.3M | $11.7M | $9.4M | $4.9M | $8.9M | $8.9M | $11.4M | $14.3M |
| Deferred revenue (current) | $42.5M | $69.7M | $56.1M | $58.8M | $67.0M | $71.5M | $53.3M | $52.2M |
| Short-term debt | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $231.6M | $231.2M | $230.4M |
| Long-term debt | $151.9M | $151.7M | $151.6M | $151.5M | $151.4M | $151.3M | $151.2M | $114.6M |
| Other non-current liabilities | $775.0K | $841.0K | $798.0K | $40.0K | $52.0K | $408.0K | $154.0K | $3.4M |
| Common stock & paid-in capital | $1.62B | $1.61B | $1.61B | $1.60B | $1.60B | $1.59B | $1.55B | $1.52B |
| Retained earnings | -$1.52B | -$1.48B | -$1.36B | -$1.27B | -$1.25B | -$1.21B | -$1.19B | -$1.17B |
| Accumulated other comprehensive income (loss) | $1.0M | $1.0M | $1.6M | $1.5M | $2.2M | $140.0K | -$835.0K | -$110.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $275.0K | $18.5M | $9.9M | -$464.0K | -$9.0M | $280.0K | -$3.5M | $6.2M |
| Investing cash flow | $902.0K | -$9.4M | $1.0M | -$9.4M | -$52.2M | $96.8M | -$112.7M | $7.6M |
| Financing cash flow | -$450.0K | -$4.0K | -$434.0K | -$537.0K | -$230.1M | -$4.7M | $37.7M | $112.5M |
| Free cash flow | -$70.0K | $18.2M | $9.6M | -$719.0K | -$8.8M | -$390.0K | -$3.9M | $5.5M |
| Capital expenditures | $345.0K | $338.0K | $273.0K | $255.0K | -$230.0K | $670.0K | $413.0K | $705.0K |
| Share-based compensation | $2.7M | $3.8M | $4.1M | $7.0M | $8.3M | $7.5M | $10.8M | $9.5M |
| Deferred income taxes | $60.0K | $44.0K | $195.0K | $43.0K | -$224.0K | $67.0K | $594.0K | -$533.0K |
| Change in accounts receivable | -$11.3M | $591.0K | -$900.0K | -$7.9M | $4.6M | $6.1M | $2.0M | -$4.3M |
| Purchases of investments | $18.8M | $24.9M | $7.9M | $10.5M | $46.8M | $0 | $118.1M | $0 |
| Share repurchases | $0 | $0 | $0 | $0 | $0 | $5.0M | $0 | $0 |
| Debt issued | — | — | $0 | $0 | — | — | $36.8M | $115.5M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $311.1M | $306.6M | $295.9M | $276.2M | $241.9M |
| Operating income | -$160.9M | -$69.8M | -$126.9M | -$140.0M | -$143.7M |
| Net income | -$178.0M | -$69.5M | -$118.1M | -$137.4M | -$153.2M |
| EPS (diluted) | $-2.55 | $-1.15 | $-2.09 | $-2.63 | $-3.23 |
| EPS (basic) | $-2.55 | $-1.15 | $-2.09 | $-2.56 | $-3.23 |
| Operating margin | -$52 | -$23 | -$43 | -$51 | -$59 |
| Net margin | -$57 | -$23 | -$40 | -$50 | -$63 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $502.6M | $858.9M | $701.8M | $752.3M | $832.1M |
| Total liabilities | $256.9M | $493.7M | $334.9M | $327.3M | $310.0M |
| Stockholders' equity | $245.8M | $365.2M | $366.9M | $425.0M | $522.1M |
| Total current assets | $169.3M | $465.6M | $393.4M | $427.8M | $508.4M |
| Total current liabilities | $89.6M | $325.9M | $89.0M | $82.5M | $93.1M |
| Cash & equivalents | $50.8M | $249.6M | $106.3M | $116.3M | $193.2M |
| Marketable securities (current) | $44.9M | $142.4M | $211.5M | $247.2M | $251.8M |
| Accounts receivable | $59.1M | $57.2M | $60.3M | $48.0M | $48.8M |
| Property, plant & equipment | $33.8M | $29.4M | $25.7M | $25.9M | $23.3M |
| Goodwill | $209.1M | $259.8M | $190.7M | $186.0M | $170.0M |
| Intangible assets | $77.7M | $86.1M | $73.4M | $92.2M | $104.8M |
| Other non-current assets | $6.1M | $6.0M | $4.7M | $3.7M | $4.5M |
| Accounts payable | $9.4M | $11.4M | $6.6M | $4.4M | $4.7M |
| Deferred revenue (current) | $56.1M | $53.3M | $55.8M | $55.0M | $56.6M |
| Short-term debt | $1.6M | $231.2M | $0 | — | — |
| Long-term debt | $151.6M | $151.2M | $228.0M | $226.5M | $180.9M |
| Other non-current liabilities | $798.0K | $154.0K | $74.0K | $121.0K | $113.0K |
| Common stock & paid-in capital | $1.61B | $1.55B | $1.48B | $1.42B | $1.40B |
| Retained earnings | -$1.36B | -$1.19B | -$1.12B | -$999.0M | -$878.9M |
| Accumulated other comprehensive income (loss) | $1.6M | -$835.0K | $33.0K | -$648.0K | -$67.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $731.0K | $14.6M | -$33.1M | -$35.3M | -$23.1M |
| Investing cash flow | $36.2M | -$22.9M | $20.3M | -$39.0M | -$139.7M |
| Financing cash flow | -$235.8M | $151.7M | $2.7M | -$2.6M | $264.1M |
| Free cash flow | -$237.0K | $12.9M | -$34.3M | -$37.4M | -$33.6M |
| Capital expenditures | $968.0K | $1.6M | $1.2M | $2.2M | $10.4M |
| Share-based compensation | $27.0M | $40.1M | $55.8M | $72.1M | $65.1M |
| Deferred income taxes | $81.0K | $77.0K | $8.0K | -$4.5M | -$7.1M |
| Change in accounts receivable | $1.8M | -$4.3M | $13.7M | -$788.0K | -$102.0K |
| Purchases of investments | $65.1M | $168.3M | $290.8M | $309.0M | $261.4M |
| Share repurchases | $5.0M | $0 | $1.8M | $8.4M | $0 |
| Debt issued | $0 | $152.3M | $0 | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding HCAT as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-01 to 2026-10-01
Recent transactions
- Insiders have net bought 59,000 shares over the last 182 days, across 1 purchase and 0 sales.
- Most recent: Reller Tami (Reporting person) — Grant / award of 128,851 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)59,000 sh(1 txns)
Sales (open market)0 sh(0 txns)
Net Shares+59,000
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Reller Tami | Reporting person | Grant / award | 2026-10-01 | 128,851 |
| Kohl Simeon | Chief Executive Officer | Grant / award | 2026-09-14 | 2,747,385 |
| Albert Benjamin | CEO | Tax withholding | 2026-09-10 | 35,244 |
| Larson-Green Julie | Reporting person | Grant / award | 2026-09-01 | 9,766 |
| Alger Jason | Chief Financial Officer | Tax withholding | 2026-09-01 | 17,973 |
| Landry Benjamin | General Counsel | Tax withholding | 2026-09-01 | 13,167 |
| Hoggard Green Jill | Reporting person | Grant / award | 2026-07-16 | 80,691 |
| Nelson Steven H | Reporting person | Grant / award | 2026-07-16 | 80,691 |
| Spencer Justin | Reporting person | Grant / award | 2026-07-16 | 80,691 |
| Llewelyn Linda | Chief People Officer | Tax withholding | 2026-06-01 | 8,519 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Reller Tami | Reporting person | Grant / award | 128,851 | $0.00 |
| 2026-09-14 | Kohl Simeon | Chief Executive Officer | Grant / award | 2,747,385 | $0.00 |
| 2026-09-14 | Kohl Simeon | Chief Executive Officer | Open market purchase | 59,000 | $1.79 |
| 2026-09-10 | Albert Benjamin | CEO | Tax withholding | 35,244 | $1.67 |
| 2026-09-01 | Larson-Green Julie | Reporting person | Grant / award | 9,766 | $0.00 |
| 2026-09-01 | Alger Jason | Chief Financial Officer | Tax withholding | 17,973 | $1.70 |
| 2026-09-01 | Albert Benjamin | CEO | Tax withholding | 321 | $1.70 |
| 2026-09-01 | Landry Benjamin | General Counsel | Tax withholding | 13,167 | $1.70 |
| 2026-07-16 | Hoggard Green Jill | Reporting person | Grant / award | 80,691 | $0.00 |
| 2026-07-16 | Larson-Green Julie | Reporting person | Grant / award | 80,691 | $0.00 |
| 2026-07-16 | Nelson Steven H | Reporting person | Grant / award | 80,691 | $0.00 |
| 2026-07-16 | Spencer Justin | Reporting person | Grant / award | 80,691 | $0.00 |
| 2026-06-10 | Albert Benjamin | CEO | Tax withholding | 34,485 | $1.69 |
| 2026-06-01 | Albert Benjamin | CEO | Tax withholding | 336 | $1.37 |
| 2026-06-01 | Llewelyn Linda | Chief People Officer | Tax withholding | 8,519 | $1.37 |
| 2026-06-01 | Alger Jason | Chief Financial Officer | Tax withholding | 18,804 | $1.37 |
| 2026-06-01 | Landry Benjamin | General Counsel | Tax withholding | 13,779 | $1.37 |
| 2026-06-01 | Larson-Green Julie | Reporting person | Grant / award | 12,710 | $0.00 |
| 2026-05-01 | Nelson Steven H | Reporting person | Grant / award | 154,808 | $0.00 |
| 2026-05-01 | Albert Benjamin | CEO | Tax withholding | 310 | $1.34 |
| 2026-04-29 | Albert Benjamin | CEO | Grant / award | 1,124 | $0.00 |
| 2026-03-10 | Albert Benjamin | CEO | Tax withholding | 70,455 | $1.85 |
| 2026-03-02 | Landry Benjamin | General Counsel | Tax withholding | 20,838 | $1.66 |
| 2026-03-02 | Alger Jason | Chief Financial Officer | Tax withholding | 26,970 | $1.66 |
| 2026-03-02 | Albert Benjamin | CEO | Tax withholding | 4,966 | $1.66 |
| 2026-03-02 | Llewelyn Linda | Chief People Officer | Tax withholding | 13,836 | $1.66 |
| 2026-03-01 | Larson-Green Julie | Reporting person | Grant / award | 8,361 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:54 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-16 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-09-14 | 8-K | 2026-09-11 | View on SEC.gov → |
| 2026-09-11 | 4 | 2026-09-10 | View on SEC.gov → |
| 2026-09-08 | 8-K | 2026-09-04 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-09-03 | 4 | 2026-09-01 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-07-20 | 4 | 2026-07-16 | View on SEC.gov → |
Recent news
Headlines about HCAT (Health Catalyst, Inc). Links open the publisher — we don’t host full articles.
-
HCAT261016C00002500 interactive stock chart | HCAT Oct 2026 2.500 call stock
Yahoo Finance UK · 2026-10-19 -
HCAT Jan 2027 2.500 call (HCAT270115C00002500) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-17 -
Data Analytics Stocks Q2 Results: Benchmarking Health Catalyst (NASDAQ:HCAT)
Yahoo · 2026-10-15 -
3 Cash-Producing Stocks with Warning Signs
Yahoo · 2026-10-14 -
3 Unprofitable Stocks That Fall Short
Yahoo Finance · 2026-09-25 -
Health Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth Risks
Yahoo Finance · 2026-09-19 -
3 Small-Cap Stocks We Steer Clear Of
Yahoo Finance · 2026-09-18 -
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance · 2026-09-14
No headlines in this category right now — try “All”.